Treatment of vitiligo by topical calcipotriol.
OBJECTIVE
Evaluation of the efficiency of topical calcipotriol monotherapy in vitiligo.


METHODS
This was a prospective, right/left comparative, open study at the Dermatology Department at the University Hospital in Nice, France. Twenty-four patients with localized or generalized vitiligo with symmetrical lesions were included. The main outcome measure was the evaluation of the percentage of repigmentation in treated target lesions and untreated control lesions for each patient.


CONCLUSIONS
Topical calcipotriol in monotherapy is not an effective treatment of vitiligo.
Chiavérini
C
C
Department of Dermatology, Archet-2 Hospital, Nice, France. christine.chiaverini@free.fr
Passeron
T
T
Ortonne
J P
JP
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D002117:Calcitriol / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D002648:Child; D003879:Dermatologic Agents / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012016:Reference Values; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014820:Vitiligo / Q000175:diagnosis / Q000188:drug therapy*
D003879:Dermatologic Agents; C055085:calcipotriene; D002117:Calcitriol